- Home
- XBIO vs YOSH Comparison
XBIO vs YOSH Comparison
Compare XBIO & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- YOSH
- Stock Information
- Founded
- XBIO N/A
- YOSH 2016
- Country
- XBIO United States
- YOSH United States
- Employees
- XBIO N/A
- YOSH N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- YOSH Restaurants
- Sector
- XBIO Health Care
- YOSH Consumer Discretionary
- Exchange
- XBIO Nasdaq
- YOSH Nasdaq
- Market Cap
- XBIO 4.2M
- YOSH 23.7M
- IPO Year
- XBIO N/A
- YOSH 2022
- Fundamental
- Price
- XBIO $3.52
- YOSH N/A
- Analyst Decision
- XBIO Hold
- YOSH
- Analyst Count
- XBIO 1
- YOSH 0
- Target Price
- XBIO N/A
- YOSH N/A
- AVG Volume (30 Days)
- XBIO 179.8K
- YOSH 5.6K
- Earning Date
- XBIO 08-12-2025
- YOSH 08-18-2025
- Dividend Yield
- XBIO N/A
- YOSH N/A
- EPS Growth
- XBIO N/A
- YOSH N/A
- EPS
- XBIO N/A
- YOSH N/A
- Revenue
- XBIO $2,582,728.00
- YOSH $13,539,317.00
- Revenue This Year
- XBIO $14.23
- YOSH N/A
- Revenue Next Year
- XBIO $7.14
- YOSH N/A
- P/E Ratio
- XBIO N/A
- YOSH N/A
- Revenue Growth
- XBIO 5.63
- YOSH 41.82
- 52 Week Low
- XBIO $2.20
- YOSH $2.71
- 52 Week High
- XBIO $5.27
- YOSH $22.50
- Technical
- Relative Strength Index (RSI)
- XBIO 60.67
- YOSH 34.47
- Support Level
- XBIO $3.52
- YOSH $9.19
- Resistance Level
- XBIO $4.09
- YOSH $10.00
- Average True Range (ATR)
- XBIO 0.54
- YOSH 0.76
- MACD
- XBIO 0.09
- YOSH -0.16
- Stochastic Oscillator
- XBIO 45.17
- YOSH 14.44
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
About YOSH Yoshiharu Global Co.
Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.